Clinical Translation of Pluripotent Stem Cell-based Therapies: Successes and Challenges

Overview

Journal Development

Specialty Biology

Date 2024 Apr 2

PMID 38564308

Authors

Josefine Ragard Christiansen

Agnete Kirkeby

Affiliations

Soon will be listed here.

Abstract

The translational stem cell research field has progressed immensely in the past decade. Development and refinement of differentiation protocols now allows the generation of a range of cell types, such as pancreatic β-cells and dopaminergic neurons, from human pluripotent stem cells (hPSCs) in an efficient and good manufacturing practice-compliant fashion. This has led to the initiation of several clinical trials using hPSC-derived cells to replace lost or dysfunctional cells, demonstrating evidence of both safety and efficacy. Here, we highlight successes from some of the hPSC-based trials reporting early signs of efficacy and discuss common challenges in clinical translation of cell therapies.

Citing Articles

Phase I-IIa clinical trial to evaluate the safety, feasibility and efficacy of the use of a palate mucosa generated by tissue engineering for the treatment of children with cleft palate: the BIOCLEFT study protocol.

Espana-Lopez A, Fernandez-Valades R, Cubiles E, Garzon I, Martin-Piedra M, Carriel V BMJ Open. 2024; 14(12):e093491.

PMID: 39638596 PMC: 11624797. DOI: 10.1136/bmjopen-2024-093491.

References

Shapiro A, Lakey J, Ryan E, Korbutt G, Toth E, Warnock G . Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000; 343(4):230-8. DOI: 10.1056/NEJM200007273430401. View

Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K . Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5):861-72. DOI: 10.1016/j.cell.2007.11.019. View

Veres A, Faust A, Bushnell H, Engquist E, Kenty J, Harb G . Charting cellular identity during human in vitro β-cell differentiation. Nature. 2019; 569(7756):368-373. PMC: 6903417. DOI: 10.1038/s41586-019-1168-5. View

Wang X, Gao M, Wang Y, Zhang Y . The progress of pluripotent stem cell-derived pancreatic β-cells regeneration for diabetic therapy. Front Endocrinol (Lausanne). 2022; 13:927324. PMC: 9365963. DOI: 10.3389/fendo.2022.927324. View

DAmour K, Bang A, Eliazer S, Kelly O, Agulnick A, Smart N . Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol. 2006; 24(11):1392-401. DOI: 10.1038/nbt1259. View

Schwartz S, Hubschman J, Heilwell G, Franco-Cardenas V, Pan C, Ostrick R . Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012; 379(9817):713-20. DOI: 10.1016/S0140-6736(12)60028-2. View

Hunt R, Girskis K, Rubenstein J, Alvarez-Buylla A, Baraban S . GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior. Nat Neurosci. 2013; 16(6):692-7. PMC: 3665733. DOI: 10.1038/nn.3392. View

Kim T, Piao J, Koo S, Kriks S, Chung S, Betel D . Biphasic Activation of WNT Signaling Facilitates the Derivation of Midbrain Dopamine Neurons from hESCs for Translational Use. Cell Stem Cell. 2021; 28(2):343-355.e5. PMC: 8006469. DOI: 10.1016/j.stem.2021.01.005. View

Lu B, Malcuit C, Wang S, Girman S, Francis P, Lemieux L . Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells. 2009; 27(9):2126-35. DOI: 10.1002/stem.149. View

10.

Cichocki F, Bjordahl R, Goodridge J, Mahmood S, Gaidarova S, Abujarour R . Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma. Nat Commun. 2022; 13(1):7341. PMC: 9709157. DOI: 10.1038/s41467-022-35127-2. View

11.

Nolbrant S, Heuer A, Parmar M, Kirkeby A . Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation. Nat Protoc. 2017; 12(9):1962-1979. DOI: 10.1038/nprot.2017.078. View

12.

McKenna S, Ehsanian R, Liu C, Steinberg G, Jones L, Lebkowski J . Ten-year safety of pluripotent stem cell transplantation in acute thoracic spinal cord injury. J Neurosurg Spine. 2022; 37(3):321-330. DOI: 10.3171/2021.12.SPINE21622. View

13.

Hogrebe N, Ishahak M, Millman J . Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes. Cell Stem Cell. 2023; 30(5):530-548. PMC: 10167558. DOI: 10.1016/j.stem.2023.04.002. View

14.

Liang Q, Monetti C, Shutova M, Neely E, Hacibekiroglu S, Yang H . Linking a cell-division gene and a suicide gene to define and improve cell therapy safety. Nature. 2018; 563(7733):701-704. DOI: 10.1038/s41586-018-0733-7. View

15.

Yoshida S, Kato T, Sato Y, Umekage M, Ichisaka T, Tsukahara M . A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population. Med. 2022; 4(1):51-66.e10. DOI: 10.1016/j.medj.2022.10.003. View

16.

Karbassi E, Fenix A, Marchiano S, Muraoka N, Nakamura K, Yang X . Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine. Nat Rev Cardiol. 2020; 17(6):341-359. PMC: 7239749. DOI: 10.1038/s41569-019-0331-x. View

17.

Steinbeck J, Choi S, Mrejeru A, Ganat Y, Deisseroth K, Sulzer D . Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model. Nat Biotechnol. 2015; 33(2):204-9. PMC: 5117952. DOI: 10.1038/nbt.3124. View

18.

Kirkeby A, Grealish S, Wolf D, Nelander J, Wood J, Lundblad M . Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep. 2012; 1(6):703-14. DOI: 10.1016/j.celrep.2012.04.009. View

19.

Hu X, White K, Olroyd A, DeJesus R, Dominguez A, Dowdle W . Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques. Nat Biotechnol. 2023; 42(3):413-423. PMC: 10940156. DOI: 10.1038/s41587-023-01784-x. View

20.

Sun X, Wu J, Qiang B, Romagnuolo R, Gagliardi M, Keller G . Transplanted microvessels improve pluripotent stem cell-derived cardiomyocyte engraftment and cardiac function after infarction in rats. Sci Transl Med. 2020; 12(562). DOI: 10.1126/scitranslmed.aax2992. View